AXSM · Axsome Therapeutics, Inc.
Market Cap
$10.83B
Shares
52.38M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1579428
CUSIP
05464T104
13F (30d)
327 filings
325 filers
Visit website
Investor relations